Literature DB >> 21447026

Endovascular treatment of iatrogenic intracranial pseudoaneurysm following stent angioplasty.

Jihe Lim1, Sang Hyun Suh, Kyung-Yul Lee, Chang Ki Hong, Seoung Woo Park.   

Abstract

Intracranial pseudoaneurysm (IPA) is a rare disease entity associated with blunt trauma or penetration injury and less likely surgical or endovascular procedure. Decision of the therapeutic option is difficult and challenging in the treatment of iatrogenic pseudoaneurysm from the middle cerebral artery (MCA) that is necessary to maintain. We report our experience of reconstructive treatment of iatrogenic IPA, which was developed after stenting and balloon angioplasty, in the left MCA with overlapping Enterprise stents.
Copyright © 2011 by the American Society of Neuroimaging.

Entities:  

Mesh:

Year:  2011        PMID: 21447026     DOI: 10.1111/j.1552-6569.2011.00591.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  4 in total

1.  Intracranial pseudoaneurysm after intracranial pressure monitor placement.

Authors:  Kushal J Shah; Aaron M Jones; Paul M Arnold; Koji Ebersole
Journal:  BMJ Case Rep       Date:  2014-12-12

2.  Endovascular management of spontaneous intracranial pseudoaneurysms in a pediatric patient with Noonan syndrome. A mere coincidence or a possible association with the disorder?

Authors:  Sofia Athanasiou; Christina Aslanidi; Vasileios Mamalis; George Markogiannakis; Antonios Tsanis; Eftichios Arhontakis
Journal:  Surg Neurol Int       Date:  2021-10-25

3.  Repair of internal carotid artery injury with aneurysm clip during endoscopic endonasal surgery: illustrative case.

Authors:  David Fustero de Miguel; Laura Beatriz López López; Amanda Avedillo Ruidíaz; Javier Orduna Martínez; Juan Casado Pellejero; Jesús Adrián Moles Herbera
Journal:  J Neurosurg Case Lessons       Date:  2021-02-08

Review 4.  Intracranial Pseudoaneurysms: Evaluation and Management.

Authors:  Yongtao Zheng; Zheng Lu; Jianguo Shen; Feng Xu
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.